Veracyte Inc. (VCYT) — closed signal from July 26, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on October 24, 2025.
Predicted vs. what happened
What happened
Reached its target in 41 days.
The thesis — published July 26, 2025
Veracyte will soon be added to the S&P SmallCap 600 index. When this happens many index-tracking funds must buy the stock, often lifting prices by roughly 10-15%. Big-name investor Cathie Wood already picked up $6.2 million of shares on 26 July, drawing fresh attention. Trading activity remains healthy, not frantic, suggesting more room for the price to climb toward about $32 over the next three months.
Primary drivers
- Joining the S&P 600 means index funds will soon have to buy the shares
- Cathie Wood's ARK fund purchase puts the company on more investors' radar
- Moderate trading volume shows interest without the price looking overstretched
- High-margin repeat test sales give the business steady, growing cash flow
How it played out
VCYT: target reached in 41 days
Lyra published VCYT at $25.25 on 2025-07-26, with an expected gain of 28% toward $32.32 over a short-term window ending 2025-10-24. The thesis pointed to Veracyte joining the S&P 600, expected buying by index funds, Cathie Wood's ARK fund purchase, moderate trading volume, and high-margin repeat test sales.
The stock reached the target in 41 days. It later peaked at $37.07 on 2025-10-20, a 46.8% gain from publication. It ended the window at $36.73, still above the target. The published thesis played out, and the move went beyond the stated price goal.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.